- Previous Close
114.00 - Open
114.00 - Bid 114.00 x --
- Ask 115.00 x --
- Day's Range
113.00 - 115.00 - 52 Week Range
107.00 - 228.00 - Volume
824,000 - Avg. Volume
1,394,973 - Market Cap (intraday)
450.3B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
PT UBC Medical Indonesia Tbk distributes medical devices in Indonesia. It operates in two segments, Medical Disposables and Consumables, and Diagnostics and Equipment. The company offers next generation molecular, retina AI, infectious disease, HPV DNA test, real time PCR, TB management, and newborn screening products. PT UBC Medical Indonesia Tbk was founded in 2014 and is based in Jakarta Timur, Jakarta. PT UBC Medical Indonesia Tbk operates as a subsidiary of PT Optel Investama Mulia.
www.ubcindonesia.comRecent News: LABS.JK
View MorePerformance Overview: LABS.JK
Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is IDX COMPOSITE (^JKSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LABS.JK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LABS.JK
View MoreValuation Measures
Market Cap
450.30B
Enterprise Value
450.30B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
1.60%
Return on Assets (ttm)
2.71%
Return on Equity (ttm)
4.52%
Revenue (ttm)
136.7B
Net Income Avi to Common (ttm)
2.19B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
43.34B
Total Debt/Equity (mrq)
41.71%
Levered Free Cash Flow (ttm)
-34.78B